PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024-01-01 Ivanova, M.; Frascarelli, C.; Cerbelli, B.; Pignataro, M. G.; Pernazza, A.; Venetis, K.; Sajjadi, E.; Criscitiello, C.; Curigliano, G.; Guerini-Rocco, E.; Graziano, P.; Martini, M.; D'Amati, G.; Fusco, N.
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
2021-01-01 Fusco, N.; Malapelle, U.; Fassan, M.; Marchio, C.; Buglioni, S.; Zupo, S.; Criscitiello, C.; Vigneri, P.; Dei Tos, A. P.; Maiorano, E.; Viale, G.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
2023-01-01 Zattarin, Emma; Presti, Daniele; Mariani, Luigi; Sposetti, Caterina; Leporati, Rita; Menichetti, Alice; Corti, Chiara; Benvenuti, Chiara; Fucà, Giovanni; Lobefaro, Riccardo; Ligorio, Francesca; Provenzano, Leonardo; Vingiani, Andrea; Del Vecchio, Marta; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi; Esposito, Andrea; Giorgi, Carlo Alberto; Lalli, Luca; Boldrini, Laura; Giacchetti, Pier Paolo Berton; Schianca, Ambra Carnevale; Guarneri, Valentina; Pedersini, Rebecca; Losurdo, Agnese; Zambelli, Alberto; Generali, Daniele; Criscitiello, Carmen; Curigliano, Giuseppe; Pruneri, Giancarlo; De Braud, Filippo; Dieci, Maria Vittoria; Vernieri, Claudio
Targeted therapies in breast cancer: are heart and vessels also being targeted?
2012-01-01 Criscitiello, C; Metzger-Filho, O; Saini, Ks; De Castro, G Jr; Diaz, M; La Gerche, A; De Azambuja, E; Piccart-Gebhart, Mj
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016-01-01 Curigliano, G; Cardinale, D; Dent, S; Criscitiello, C; Aseyev, O; Lenihan, D; Cipolla, Cm
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023-01-01 Fusco, Nicola; Ivanova, Mariia; Frascarelli, Chiara; Criscitiello, Carmen; Cerbelli, Bruna; Gemma Pignataro, Maria; Pernazza, Angelina; Sajjadi, Elham; Venetis, Konstantinos; Cursano, Giulia; Pagni, Fabio; Di Bella, Camillo; Accardo, Marina; Amato, Michelina; Amico, Paolo; Bartoli, Caterina; Bogina, Giuseppe; Bortesi, Laura; Boldorini, Renzo; Bruno, Sara; Cabibi, Daniela; Caruana, Pietro; Dainese, Emanuele; De Camilli, Elisa; Dell’Anna, Vladimiro; Duda, Loren; Emmanuele, Carmela; Nicolò Fanelli, Giuseppe; Fernandes, Bethania; Ferrara, Gerardo; Gnetti, Letizia; Gurrera, Alessandra; Leone, Giorgia; Lucci, Raffaella; Mancini, Cristina; Marangi, Grazia; Mastropasqua, Mauro G.; Nibid, Lorenzo; Orrù, Sandra; Pastena, Maria; Peresi, Monica; Perracchio, Letizia; Santoro, Angela; Vezzosi, Vania; Zambelli, Claudia; Zuccalà, Valeria; Rizzo, Antonio; Costarelli, Leopoldo; Pietribiasi, Francesca; Santinelli, Alfredo; Scatena, Cristian; Curigliano, Giuseppe; Guerini-Rocco, Elena; Martini, Maurizio; Graziano, Paolo; Castellano, Isabella; D'Amati, Giulia
Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
2015-01-01 Esposito, Angela; Criscitiello, Carmen; Curigliano, Giuseppe
Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer
2021-01-01 Corti, C; Criscitiello, C
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?
2015-01-01 Criscitiello, C; Giuliano, M; Curigliano, G; De Laurentiis, M; Arpino, G; Carlomagno, N; De Placido, S; Golshan, M; Santangelo, M
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis
2012-01-01 Ignatiadis, M; Singhal, Sk; Desmedt, C; Haibe-Kains, B; Criscitiello, C; Andre, F; Loi, S; Piccart, M; Michiels, S; Sotiriou, C
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
2020-01-01 De Azambuja, E.; Trapani, D.; Loibl, S.; Delaloge, S.; Senkus, E.; Criscitiello, C.; Poortman, P.; Gnant, M.; Di Cosimo, S.; Cortes, J.; Cardoso, F.; Paluch-Shimon, S.; Curigliano, G.
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
2021-01-01 Tarantino, P.; Gandini, S.; Trapani, D.; Criscitiello, C.; Curigliano, G.
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine
2015-01-01 Curigliano, G; Bagnardi, V; Bertolini, F; Alcalay, M; Locatelli, Ma; Fumagalli, L; Rabascio, C; Calleri, A; Adamoli, L; Criscitiello, C; Viale, G; Goldhirsch, A
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
2014-01-01 Criscitiello, C.; Gelao, L.; Viale, G.; Esposito, A.; Curigliano, G.
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025-01-01 Venetis, Konstantinos; Frascarelli, Chiara; Bielo, Luca Boscolo; Cursano, Giulia; Adorisio, Riccardo; Ivanova, Mariia; Mane, Eltjona; Peruzzo, Virginia; Concardi, Alberto; Negrelli, Mariachiara; D'Ercole, Marianna; Porta, Francesca Maria; Zhan, Yinxiu; Marra, Antonio; Trapani, Dario; Criscitiello, Carmen; Curigliano, Giuseppe; Guerini-Rocco, Elena; Fusco, Nicola
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017-01-01 Solinas, Cinzia; Carbognin, Luisa; De Silva, Pushpamali; Criscitiello, Carmen; Lambertini, Matteo
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents
2020-01-01 Tarantino, P.; Marra, A.; Gandini, S.; Minotti, M.; Pricolo, P.; Signorelli, G.; Criscitiello, C.; Locatelli, M.; Belli, C.; Bellomi, M.; Curigliano, G.
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
2024-01-01 Mazzarella, Luca; Giugliano, Federica; Nicolo, Eleonora; Esposito, Angela; Crimini, Edoardo; Tini, Giulia; Uliano, Jacopo; Corti, Chiara; D'Amico, Paolo; Aliaga, Pamela Trillo; Valenza, Carmine; Repetto, Matteo; Antonarelli, Gabriele; Ascione, Liliana; Vivanet, Grazia; Berton Giachetti, Pier Paolo Maria; Minchella, Ida; Belli, Carmen; Locatelli, Marzia; Criscitiello, Carmen; Curigliano, Giuseppe
Targeting fibroblast growth factor receptor pathway in breast cancer
2015-01-01 Criscitiello, C.; Esposito, A.; De Placido, S.; Curigliano, G.
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer
2017-01-01 Curigliano, G.; Criscitiello, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores | 1-gen-2024 | Ivanova, M.; Frascarelli, C.; Cerbelli, B.; Pignataro, M. G.; Pernazza, A.; Venetis, K.; Sajjadi, E.; Criscitiello, C.; Curigliano, G.; Guerini-Rocco, E.; Graziano, P.; Martini, M.; D'Amati, G.; Fusco, N. | |
| PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer | 1-gen-2021 | Fusco, N.; Malapelle, U.; Fassan, M.; Marchio, C.; Buglioni, S.; Zupo, S.; Criscitiello, C.; Vigneri, P.; Dei Tos, A. P.; Maiorano, E.; Viale, G. | |
| Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors | 1-gen-2023 | Zattarin, Emma; Presti, Daniele; Mariani, Luigi; Sposetti, Caterina; Leporati, Rita; Menichetti, Alice; Corti, Chiara; Benvenuti, Chiara; Fucà, Giovanni; Lobefaro, Riccardo; Ligorio, Francesca; Provenzano, Leonardo; Vingiani, Andrea; Del Vecchio, Marta; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi; Esposito, Andrea; Giorgi, Carlo Alberto; Lalli, Luca; Boldrini, Laura; Giacchetti, Pier Paolo Berton; Schianca, Ambra Carnevale; Guarneri, Valentina; Pedersini, Rebecca; Losurdo, Agnese; Zambelli, Alberto; Generali, Daniele; Criscitiello, Carmen; Curigliano, Giuseppe; Pruneri, Giancarlo; De Braud, Filippo; Dieci, Maria Vittoria; Vernieri, Claudio | |
| Targeted therapies in breast cancer: are heart and vessels also being targeted? | 1-gen-2012 | Criscitiello, C; Metzger-Filho, O; Saini, Ks; De Castro, G Jr; Diaz, M; La Gerche, A; De Azambuja, E; Piccart-Gebhart, Mj | |
| Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management | 1-gen-2016 | Curigliano, G; Cardinale, D; Dent, S; Criscitiello, C; Aseyev, O; Lenihan, D; Cipolla, Cm | |
| Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey | 1-gen-2023 | Fusco, Nicola; Ivanova, Mariia; Frascarelli, Chiara; Criscitiello, Carmen; Cerbelli, Bruna; Gemma Pignataro, Maria; Pernazza, Angelina; Sajjadi, Elham; Venetis, Konstantinos; Cursano, Giulia; Pagni, Fabio; Di Bella, Camillo; Accardo, Marina; Amato, Michelina; Amico, Paolo; Bartoli, Caterina; Bogina, Giuseppe; Bortesi, Laura; Boldorini, Renzo; Bruno, Sara; Cabibi, Daniela; Caruana, Pietro; Dainese, Emanuele; De Camilli, Elisa; Dell’Anna, Vladimiro; Duda, Loren; Emmanuele, Carmela; Nicolò Fanelli, Giuseppe; Fernandes, Bethania; Ferrara, Gerardo; Gnetti, Letizia; Gurrera, Alessandra; Leone, Giorgia; Lucci, Raffaella; Mancini, Cristina; Marangi, Grazia; Mastropasqua, Mauro G.; Nibid, Lorenzo; Orrù, Sandra; Pastena, Maria; Peresi, Monica; Perracchio, Letizia; Santoro, Angela; Vezzosi, Vania; Zambelli, Claudia; Zuccalà, Valeria; Rizzo, Antonio; Costarelli, Leopoldo; Pietribiasi, Francesca; Santinelli, Alfredo; Scatena, Cristian; Curigliano, Giuseppe; Guerini-Rocco, Elena; Martini, Maurizio; Graziano, Paolo; Castellano, Isabella; D'Amati, Giulia | |
| Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer | 1-gen-2015 | Esposito, Angela; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer | 1-gen-2021 | Corti, C; Criscitiello, C | |
| Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do? | 1-gen-2015 | Criscitiello, C; Giuliano, M; Curigliano, G; De Laurentiis, M; Arpino, G; Carlomagno, N; De Placido, S; Golshan, M; Santangelo, M | |
| Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis | 1-gen-2012 | Ignatiadis, M; Singhal, Sk; Desmedt, C; Haibe-Kains, B; Criscitiello, C; Andre, F; Loi, S; Piccart, M; Michiels, S; Sotiriou, C | |
| ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer | 1-gen-2020 | De Azambuja, E.; Trapani, D.; Loibl, S.; Delaloge, S.; Senkus, E.; Criscitiello, C.; Poortman, P.; Gnant, M.; Di Cosimo, S.; Cortes, J.; Cardoso, F.; Paluch-Shimon, S.; Curigliano, G. | |
| Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials | 1-gen-2021 | Tarantino, P.; Gandini, S.; Trapani, D.; Criscitiello, C.; Curigliano, G. | |
| Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine | 1-gen-2015 | Curigliano, G; Bagnardi, V; Bertolini, F; Alcalay, M; Locatelli, Ma; Fumagalli, L; Rabascio, C; Calleri, A; Adamoli, L; Criscitiello, C; Viale, G; Goldhirsch, A | |
| Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy | 1-gen-2014 | Criscitiello, C.; Gelao, L.; Viale, G.; Esposito, A.; Curigliano, G. | |
| Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact | 1-gen-2025 | Venetis, Konstantinos; Frascarelli, Chiara; Bielo, Luca Boscolo; Cursano, Giulia; Adorisio, Riccardo; Ivanova, Mariia; Mane, Eltjona; Peruzzo, Virginia; Concardi, Alberto; Negrelli, Mariachiara; D'Ercole, Marianna; Porta, Francesca Maria; Zhan, Yinxiu; Marra, Antonio; Trapani, Dario; Criscitiello, Carmen; Curigliano, Giuseppe; Guerini-Rocco, Elena; Fusco, Nicola | |
| Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art | 1-gen-2017 | Solinas, Cinzia; Carbognin, Luisa; De Silva, Pushpamali; Criscitiello, Carmen; Lambertini, Matteo | |
| Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents | 1-gen-2020 | Tarantino, P.; Marra, A.; Gandini, S.; Minotti, M.; Pricolo, P.; Signorelli, G.; Criscitiello, C.; Locatelli, M.; Belli, C.; Bellomi, M.; Curigliano, G. | |
| Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population | 1-gen-2024 | Mazzarella, Luca; Giugliano, Federica; Nicolo, Eleonora; Esposito, Angela; Crimini, Edoardo; Tini, Giulia; Uliano, Jacopo; Corti, Chiara; D'Amico, Paolo; Aliaga, Pamela Trillo; Valenza, Carmine; Repetto, Matteo; Antonarelli, Gabriele; Ascione, Liliana; Vivanet, Grazia; Berton Giachetti, Pier Paolo Maria; Minchella, Ida; Belli, Carmen; Locatelli, Marzia; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Targeting fibroblast growth factor receptor pathway in breast cancer | 1-gen-2015 | Criscitiello, C.; Esposito, A.; De Placido, S.; Curigliano, G. | |
| Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer | 1-gen-2017 | Curigliano, G.; Criscitiello, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26842
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269046
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24589
- reserved1362
- open891